About
Symphogen develops antibody-based therapies for the treatment of cancer and other diseases by using proprietary antibody mixture technology to create synergistic effects.
Explore Symphogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.